Stay updated on Upadacitinib in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in Atopic Dermatitis Clinical Trial page.

Latest updates to the Upadacitinib in Atopic Dermatitis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check18 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, and API users can provide input before this change. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.4%
- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe page has removed a citation regarding a study on upadacitinib for atopic dermatitis, which is a significant change in the core content.SummaryDifference0.1%
- Check46 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check53 days agoChange DetectedThe web page has updated its date information, adding several new dates in 2025 while removing older dates from 2024.SummaryDifference0.2%
- Check61 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the details of a study evaluating upadacitinib for atopic dermatitis, including its objectives, methodology, and inclusion/exclusion criteria. The revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference6%
Stay in the know with updates to Upadacitinib in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Atopic Dermatitis Clinical Trial page.